Literature DB >> 20836544

Carboxyl-terminated PAMAM-SN38 conjugates: synthesis, characterization, and in vitro evaluation.

Nirmalkumar Vijayalakshmi1, Abhijit Ray, Alexander Malugin, Hamidreza Ghandehari.   

Abstract

In this work, carboxyl-terminated PAMAM G-3.5 was covalently attached to SN38 via glycine and β-alanine spacers. The conjugates were stable at pH 7.4 and moderately hydrolyzed in cell culture media and rat plasma. Similarly to SN38 but to a lesser extent, both conjugates inhibited proliferation of human colorectal cancer HCT-116 cells, arrested the cell cycle in the G(2)/M phase, and led to nuclear fragmentation. However, activity of the conjugate with glycine spacer (IC(50) = 129 nM) was higher compared to that of the β-alanine linked conjugate (IC(50) = 387 nM). These PAMAM-SN38 conjugates have the potential for targeted therapy of colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20836544      PMCID: PMC3197241          DOI: 10.1021/bc100094z

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  27 in total

1.  The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B.

Authors:  Y P Tsao; P D'Arpa; L F Liu
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

2.  Polymer therapeutics designed for a combination therapy of hormone-dependent cancer.

Authors:  María J Vicent; Francesca Greco; Robert I Nicholson; Alison Paul; Peter C Griffiths; Ruth Duncan
Journal:  Angew Chem Int Ed Engl       Date:  2005-06-27       Impact factor: 15.336

3.  Downregulation of topoisomerase I in differentiating human intestinal epithelial cells.

Authors:  H Ulukan; M T Muller; P W Swaan
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

4.  Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.

Authors:  Anil K Patri; Jolanta F Kukowska-Latallo; James R Baker
Journal:  Adv Drug Deliv Rev       Date:  2005-11-14       Impact factor: 15.470

5.  Polymer-bound camptothecin: initial biodistribution and antitumour activity studies.

Authors:  V R Caiolfa; M Zamai; A Fiorino; E Frigerio; C Pellizzoni; R d'Argy; A Ghiglieri; M G Castelli; M Farao; E Pesenti; M Gigli; F Angelucci; A Suarato
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

Review 6.  Camptothecins: a review of their chemotherapeutic potential.

Authors:  Hulya Ulukan; Peter W Swaan
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Effects of branching architecture and linker on the activity of hyperbranched polymer-drug conjugates.

Authors:  Omathanu Perumal; Jayant Khandare; Parag Kolhe; Sujatha Kannan; Mary Lieh-Lai; Rangaramanujam M Kannan
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

8.  Activity of CPT-11 (irinotecan hydrochloride), a topoisomerase I inhibitor, against human tumor colony-forming units.

Authors:  Y Shimada; M Rothenberg; S G Hilsenbeck; H A Burris; D Degen; D D Von Hoff
Journal:  Anticancer Drugs       Date:  1994-04       Impact factor: 2.248

9.  SN-38 induces cell cycle arrest and apoptosis in human testicular cancer.

Authors:  Munehisa Ueno; Shoichi Nonaka; Ryuta Yamazaki; Nobuhiro Deguchi; Masaru Murai
Journal:  Eur Urol       Date:  2002-10       Impact factor: 20.096

10.  Synthesis and in vivo antitumor activity of poly(l-glutamic acid) conjugates of 20S-camptothecin.

Authors:  Rama Bhatt; Peter de Vries; John Tulinsky; Garland Bellamy; Brian Baker; Jack W Singer; Peter Klein
Journal:  J Med Chem       Date:  2003-01-02       Impact factor: 7.446

View more
  13 in total

Review 1.  Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery.

Authors:  S Sadekar; H Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2011-09-29       Impact factor: 15.470

2.  Diaphragmatic recovery in rats with cervical spinal cord injury induced by a theophylline nanoconjugate: Challenges for clinical use.

Authors:  Fangchao Liu; Yanhua Zhang; Janelle Schafer; Guangzhao Mao; Harry G Goshgarian
Journal:  J Spinal Cord Med       Date:  2019-03-07       Impact factor: 1.985

3.  Polymeric conjugates for drug delivery.

Authors:  Nate Larson; Hamidreza Ghandehari
Journal:  Chem Mater       Date:  2012-01-04       Impact factor: 9.811

4.  Preclinical antitumor activity of a nanoparticulate SN38.

Authors:  Mazin F Al-Kasspooles; Stephen K Williamson; David Henry; Jahna Howell; Fengui Niu; Charles J Decedue; Katherine F Roby
Journal:  Invest New Drugs       Date:  2013-01-09       Impact factor: 3.850

5.  Charge affects the oral toxicity of poly(amidoamine) dendrimers.

Authors:  Giridhar Thiagarajan; Khaled Greish; Hamidreza Ghandehari
Journal:  Eur J Pharm Biopharm       Date:  2013-02-16       Impact factor: 5.571

6.  G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity.

Authors:  Deborah S Goldberg; Nirmalkumar Vijayalakshmi; Peter W Swaan; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2010-11-27       Impact factor: 9.776

7.  Advances in the application of nanotechnology in the diagnosis and treatment of gastrointestinal tumors.

Authors:  B O Sun; Yantian Fang; Zhengyang Li; Zongyou Chen; Jianbin Xiang
Journal:  Mol Clin Oncol       Date:  2014-12-02

8.  Functional-segregated coumarin-containing telodendrimer nanocarriers for efficient delivery of SN-38 for colon cancer treatment.

Authors:  Gaofei Xu; Changying Shi; Dandan Guo; Lili Wang; Yun Ling; Xiaobing Han; Juntao Luo
Journal:  Acta Biomater       Date:  2015-04-22       Impact factor: 8.947

9.  SN-38-cyclodextrin complexation and its influence on the solubility, stability, and in vitro anticancer activity against ovarian cancer.

Authors:  Kiran Kumar Vangara; Hamed Ismail Ali; Dai Lu; Jingbo Louise Liu; Srikanth Kolluru; Srinath Palakurthi
Journal:  AAPS PharmSciTech       Date:  2014-01-30       Impact factor: 3.246

10.  Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.

Authors:  S Sadekar; G Thiagarajan; K Bartlett; D Hubbard; A Ray; L D McGill; H Ghandehari
Journal:  Int J Pharm       Date:  2013-08-08       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.